ID   RBL1_HUMAN              Reviewed;        1068 AA.
AC   P28749; A8K2W5; Q4VXA0; Q8N5K6; Q9H1L5; Q9H1M1;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 3.
DT   28-JUN-2023, entry version 224.
DE   RecName: Full=Retinoblastoma-like protein 1;
DE   AltName: Full=107 kDa retinoblastoma-associated protein;
DE            Short=p107;
DE   AltName: Full=pRb1;
GN   Name=RBL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   PubMed=8319904; DOI=10.1101/gad.7.7a.1111;
RA   Zhu L., van den Heuvel S., Helin K., Fattaey A., Ewen M., Livingston D.,
RA   Dyson N., Harlow E.;
RT   "Inhibition of cell proliferation by p107, a relative of the retinoblastoma
RT   protein.";
RL   Genes Dev. 7:1111-1125(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 134-1068 (ISOFORM 1), AND PARTIAL PROTEIN
RP   SEQUENCE.
RX   PubMed=1833063; DOI=10.1016/0092-8674(91)90038-z;
RA   Ewen M.E., Xing Y., Lawrence J.B., Livingston D.M.;
RT   "Molecular cloning, chromosomal mapping, and expression of the cDNA for
RT   p107, a retinoblastoma gene product-related protein.";
RL   Cell 66:1155-1164(1991).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-52.
RX   PubMed=7791762; DOI=10.1128/mcb.15.7.3552;
RA   Zhu L., Zhu L., Xie E., Chang L.S.;
RT   "Differential roles of two tandem E2F sites in repression of the human p107
RT   promoter by retinoblastoma and p107 proteins.";
RL   Mol. Cell. Biol. 15:3552-3562(1995).
RN   [8]
RP   PROTEIN SEQUENCE OF 320-334; 364-374; 635-657; 949-977 AND 1006-1012,
RP   PHOSPHORYLATION AT THR-332; THR-369; THR-385; SER-640; SER-762; SER-964;
RP   SER-975; SER-988; THR-997 AND SER-1009, MUTAGENESIS OF SER-640; SER-643;
RP   SER-650 AND 657-LYS--LEU-660, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=11884610; DOI=10.1128/mcb.22.7.2242-2254.2002;
RA   Leng X., Noble M., Adams P.D., Qin J., Harper J.W.;
RT   "Reversal of growth suppression by p107 via direct phosphorylation by
RT   cyclin D1/cyclin-dependent kinase 4.";
RL   Mol. Cell. Biol. 22:2242-2254(2002).
RN   [9]
RP   INTERACTION WITH SV40 AND JC VIRUS LARGE T ANTIGEN (MICROBIAL INFECTION).
RX   PubMed=2546678; DOI=10.1016/0092-8674(89)90839-8;
RA   Dyson N., Buchkovich K., Whyte P., Harlow E.;
RT   "The cellular 107K protein that binds to adenovirus E1A also associates
RT   with the large T antigens of SV40 and JC virus.";
RL   Cell 58:249-255(1989).
RN   [10]
RP   INTERACTION WITH KDM5A.
RX   PubMed=7935440; DOI=10.1128/mcb.14.11.7256-7264.1994;
RA   Kim Y.W., Otterson G.A., Kratzke R.A., Coxon A.B., Kaye F.J.;
RT   "Differential specificity for binding of retinoblastoma binding protein 2
RT   to RB, p107, and TATA-binding protein.";
RL   Mol. Cell. Biol. 14:7256-7264(1994).
RN   [11]
RP   INTERACTION WITH AATF.
RX   PubMed=12450794; DOI=10.1016/s1535-6108(02)00182-4;
RA   Bruno T., De Angelis R., De Nicola F., Barbato C., Di Padova M., Corbi N.,
RA   Libri V., Benassi B., Mattei E., Chersi A., Soddu S., Floridi A.,
RA   Passananti C., Fanciulli M.;
RT   "Che-1 affects cell growth by interfering with the recruitment of HDAC1 by
RT   Rb.";
RL   Cancer Cell 2:387-399(2002).
RN   [12]
RP   PHOSPHORYLATION AT THR-369 AND SER-650.
RX   PubMed=12006580; DOI=10.1074/jbc.m200381200;
RA   Farkas T., Hansen K., Holm K., Lukas J., Bartek J.;
RT   "Distinct phosphorylation events regulate p130- and p107-mediated
RT   repression of E2F-4.";
RL   J. Biol. Chem. 277:26741-26752(2002).
RN   [13]
RP   INTERACTION WITH E2F4 AND TFDP1.
RX   PubMed=16360038; DOI=10.1016/j.cell.2005.09.044;
RA   Rubin S.M., Gall A.-L., Zheng N., Pavletich N.P.;
RT   "Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for
RT   phosphorylation-induced E2F release.";
RL   Cell 123:1093-1106(2005).
RN   [14]
RP   FUNCTION, AND IDENTIFICATION IN THE DREAM COMPLEX.
RX   PubMed=17671431; DOI=10.4161/cc.6.15.4512;
RA   Schmit F., Korenjak M., Mannefeld M., Schmitt K., Franke C., von Eyss B.,
RA   Gagrica S., Haenel F., Brehm A., Gaubatz S.;
RT   "LINC, a human complex that is related to pRB-containing complexes in
RT   invertebrates regulates the expression of G2/M genes.";
RL   Cell Cycle 6:1903-1913(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-385; SER-749 AND SER-762, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   INTERACTION WITH JC VIRUS SMALL T ANTIGEN (MICROBIAL INFECTION).
RX   PubMed=20485545; DOI=10.1371/journal.pone.0010606;
RA   Bollag B., Hofstetter C.A., Reviriego-Mendoza M.M., Frisque R.J.;
RT   "JC virus small T antigen binds phosphatase PP2A and Rb family proteins and
RT   is required for efficient viral DNA replication activity.";
RL   PLoS ONE 5:e10606-e10606(2010).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-332; THR-369; THR-385;
RP   SER-640; SER-749; SER-762; SER-988 AND SER-1041, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Key regulator of entry into cell division (PubMed:17671431).
CC       Directly involved in heterochromatin formation by maintaining overall
CC       chromatin structure and, in particular, that of constitutive
CC       heterochromatin by stabilizing histone methylation (By similarity).
CC       Recruits and targets histone methyltransferases KMT5B and KMT5C,
CC       leading to epigenetic transcriptional repression (By similarity).
CC       Controls histone H4 'Lys-20' trimethylation (By similarity). Probably
CC       acts as a transcription repressor by recruiting chromatin-modifying
CC       enzymes to promoters (By similarity). Potent inhibitor of E2F-mediated
CC       trans-activation (PubMed:8319904). May act as a tumor suppressor
CC       (PubMed:8319904). {ECO:0000250|UniProtKB:Q64701,
CC       ECO:0000269|PubMed:17671431, ECO:0000269|PubMed:8319904}.
CC   -!- SUBUNIT: Component of the DREAM complex (also named LINC complex) at
CC       least composed of E2F4, E2F5, LIN9, LIN37, LIN52, LIN54, MYBL1, MYBL2,
CC       RBL1, RBL2, RBBP4, TFDP1 and TFDP2 (PubMed:17671431, PubMed:16360038).
CC       The complex exists in quiescent cells where it represses cell cycle-
CC       dependent genes (PubMed:17671431). It dissociates in S phase when LIN9,
CC       LIN37, LIN52 and LIN54 form a subcomplex that binds to MYBL2
CC       (PubMed:17671431). Interacts with AATF (PubMed:12450794). Interacts
CC       with KDM5A (PubMed:7935440). Interacts with KMT5B and KMT5C (By
CC       similarity). Interacts with USP4 (By similarity). Interacts with RBBP9
CC       (By similarity). {ECO:0000250|UniProtKB:D3ZS28,
CC       ECO:0000250|UniProtKB:Q64701, ECO:0000269|PubMed:12450794,
CC       ECO:0000269|PubMed:16360038, ECO:0000269|PubMed:17671431,
CC       ECO:0000269|PubMed:7935440}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with SV40 and JC virus large T
CC       antigens. Large T antigen, but not E1A, binds only to the
CC       unphosphorylated form. {ECO:0000269|PubMed:2546678}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with JC virus small t antigen.
CC       {ECO:0000269|PubMed:20485545}.
CC   -!- INTERACTION:
CC       P28749; Q9BUH8: BEGAIN; NbExp=2; IntAct=EBI-971402, EBI-742722;
CC       P28749; P11802: CDK4; NbExp=2; IntAct=EBI-971402, EBI-295644;
CC       P28749; Q13574-2: DGKZ; NbExp=2; IntAct=EBI-971402, EBI-715527;
CC       P28749; Q13627: DYRK1A; NbExp=4; IntAct=EBI-971402, EBI-1053596;
CC       P28749; Q9Y463: DYRK1B; NbExp=4; IntAct=EBI-971402, EBI-634187;
CC       P28749; O43524: FOXO3; NbExp=3; IntAct=EBI-971402, EBI-1644164;
CC       P28749; Q14653: IRF3; NbExp=2; IntAct=EBI-971402, EBI-2650369;
CC       P28749; P67775: PPP2CA; NbExp=2; IntAct=EBI-971402, EBI-712311;
CC       P28749; P03129: E7; Xeno; NbExp=4; IntAct=EBI-971402, EBI-866453;
CC       P28749; P24610: Pax3; Xeno; NbExp=3; IntAct=EBI-971402, EBI-1208116;
CC       P28749; Q923E4: Sirt1; Xeno; NbExp=2; IntAct=EBI-971402, EBI-1802585;
CC       P28749; P03255; Xeno; NbExp=3; IntAct=EBI-971402, EBI-2603114;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P28749-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P28749-2; Sequence=VSP_017496;
CC   -!- PTM: Cell-cycle arrest properties are inactivated by phosphorylation on
CC       Thr-332, Ser-640, Ser-964 and Ser-975 by CDK4.
CC       {ECO:0000269|PubMed:11884610, ECO:0000269|PubMed:12006580}.
CC   -!- SIMILARITY: Belongs to the retinoblastoma protein (RB) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L14812; AAA02489.1; -; mRNA.
DR   EMBL; AK290380; BAF83069.1; -; mRNA.
DR   EMBL; AL136172; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL365505; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL391114; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW76088.1; -; Genomic_DNA.
DR   EMBL; BC032247; AAH32247.1; -; mRNA.
DR   EMBL; M74547; AAA36397.1; -; mRNA.
DR   EMBL; S78664; AAD14290.1; -; Genomic_DNA.
DR   CCDS; CCDS13289.1; -. [P28749-1]
DR   CCDS; CCDS13290.1; -. [P28749-2]
DR   PIR; A47319; A40265.
DR   RefSeq; NP_002886.2; NM_002895.4. [P28749-1]
DR   RefSeq; NP_899662.1; NM_183404.3. [P28749-2]
DR   PDB; 1H28; X-ray; 2.80 A; E/F=653-663.
DR   PDB; 4YOO; X-ray; 2.40 A; A=391-600, A=781-972.
DR   PDB; 4YOS; X-ray; 2.30 A; A=391-599.
DR   PDB; 4YOZ; X-ray; 2.25 A; A=391-593, A=777-972.
DR   PDB; 5TUV; X-ray; 2.90 A; C/F=994-1031.
DR   PDB; 7SMC; X-ray; 2.70 A; A/C=391-972.
DR   PDB; 7SMD; X-ray; 2.15 A; A=391-972.
DR   PDB; 7SME; X-ray; 2.64 A; A=391-972.
DR   PDB; 7SMF; X-ray; 3.00 A; A/C=391-972.
DR   PDBsum; 1H28; -.
DR   PDBsum; 4YOO; -.
DR   PDBsum; 4YOS; -.
DR   PDBsum; 4YOZ; -.
DR   PDBsum; 5TUV; -.
DR   PDBsum; 7SMC; -.
DR   PDBsum; 7SMD; -.
DR   PDBsum; 7SME; -.
DR   PDBsum; 7SMF; -.
DR   AlphaFoldDB; P28749; -.
DR   SMR; P28749; -.
DR   BioGRID; 111868; 96.
DR   CORUM; P28749; -.
DR   DIP; DIP-148N; -.
DR   ELM; P28749; -.
DR   IntAct; P28749; 56.
DR   MINT; P28749; -.
DR   STRING; 9606.ENSP00000362768; -.
DR   GlyGen; P28749; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P28749; -.
DR   PhosphoSitePlus; P28749; -.
DR   BioMuta; RBL1; -.
DR   DMDM; 90103515; -.
DR   EPD; P28749; -.
DR   jPOST; P28749; -.
DR   MassIVE; P28749; -.
DR   MaxQB; P28749; -.
DR   PaxDb; P28749; -.
DR   PeptideAtlas; P28749; -.
DR   ProteomicsDB; 54497; -. [P28749-1]
DR   ProteomicsDB; 54498; -. [P28749-2]
DR   Antibodypedia; 11876; 487 antibodies from 35 providers.
DR   CPTC; P28749; 1 antibody.
DR   DNASU; 5933; -.
DR   Ensembl; ENST00000344359.7; ENSP00000343646.3; ENSG00000080839.12. [P28749-2]
DR   Ensembl; ENST00000373664.8; ENSP00000362768.3; ENSG00000080839.12. [P28749-1]
DR   GeneID; 5933; -.
DR   KEGG; hsa:5933; -.
DR   MANE-Select; ENST00000373664.8; ENSP00000362768.3; NM_002895.5; NP_002886.2.
DR   UCSC; uc002xgi.5; human. [P28749-1]
DR   AGR; HGNC:9893; -.
DR   CTD; 5933; -.
DR   DisGeNET; 5933; -.
DR   GeneCards; RBL1; -.
DR   HGNC; HGNC:9893; RBL1.
DR   HPA; ENSG00000080839; Tissue enhanced (bone).
DR   MIM; 116957; gene.
DR   neXtProt; NX_P28749; -.
DR   OpenTargets; ENSG00000080839; -.
DR   PharmGKB; PA34257; -.
DR   VEuPathDB; HostDB:ENSG00000080839; -.
DR   eggNOG; KOG1010; Eukaryota.
DR   GeneTree; ENSGT00950000183202; -.
DR   HOGENOM; CLU_008943_0_1_1; -.
DR   InParanoid; P28749; -.
DR   OMA; AILCELH; -.
DR   OrthoDB; 519973at2759; -.
DR   PhylomeDB; P28749; -.
DR   TreeFam; TF105568; -.
DR   PathwayCommons; P28749; -.
DR   Reactome; R-HSA-1362277; Transcription of E2F targets under negative control by DREAM complex.
DR   Reactome; R-HSA-1362300; Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1.
DR   Reactome; R-HSA-1538133; G0 and Early G1.
DR   Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   Reactome; R-HSA-6804114; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest.
DR   Reactome; R-HSA-69205; G1/S-Specific Transcription.
DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.
DR   SignaLink; P28749; -.
DR   SIGNOR; P28749; -.
DR   BioGRID-ORCS; 5933; 27 hits in 1165 CRISPR screens.
DR   ChiTaRS; RBL1; human.
DR   EvolutionaryTrace; P28749; -.
DR   GeneWiki; Retinoblastoma-like_protein_1; -.
DR   GenomeRNAi; 5933; -.
DR   Pharos; P28749; Tbio.
DR   PRO; PR:P28749; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; P28749; protein.
DR   Bgee; ENSG00000080839; Expressed in buccal mucosa cell and 154 other tissues.
DR   ExpressionAtlas; P28749; baseline and differential.
DR   Genevisible; P28749; HS.
DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:CAFA.
DR   GO; GO:0005667; C:transcription regulator complex; IBA:GO_Central.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; IDA:MGI.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:2000773; P:negative regulation of cellular senescence; IMP:BHF-UCL.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:MGI.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0043550; P:regulation of lipid kinase activity; IDA:UniProtKB.
DR   CDD; cd20605; CYCLIN_RBL1; 1.
DR   Gene3D; 1.10.472.140; -; 1.
DR   Gene3D; 1.10.472.10; Cyclin-like; 3.
DR   IDEAL; IID00130; -.
DR   InterPro; IPR013763; Cyclin-like_dom.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR002720; RB_A.
DR   InterPro; IPR002719; RB_B.
DR   InterPro; IPR015030; RB_C.
DR   InterPro; IPR028309; RB_fam.
DR   InterPro; IPR024599; RB_N.
DR   PANTHER; PTHR13742; RETINOBLASTOMA-ASSOCIATED PROTEIN RB -RELATED; 1.
DR   PANTHER; PTHR13742:SF20; RETINOBLASTOMA-LIKE PROTEIN 1; 1.
DR   Pfam; PF11934; DUF3452; 1.
DR   Pfam; PF01858; RB_A; 1.
DR   Pfam; PF01857; RB_B; 1.
DR   Pfam; PF08934; Rb_C; 1.
DR   SMART; SM00385; CYCLIN; 1.
DR   SMART; SM01367; DUF3452; 1.
DR   SMART; SM01368; RB_A; 1.
DR   SMART; SM01369; Rb_C; 1.
DR   SUPFAM; SSF47954; Cyclin-like; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Chromatin regulator;
KW   Direct protein sequencing; Host-virus interaction; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; Transcription; Transcription regulation;
KW   Tumor suppressor.
FT   CHAIN           1..1068
FT                   /note="Retinoblastoma-like protein 1"
FT                   /id="PRO_0000167839"
FT   REGION          385..949
FT                   /note="Pocket; binds T and E1A"
FT                   /evidence="ECO:0000305|PubMed:7935440"
FT   REGION          385..584
FT                   /note="Domain A"
FT                   /evidence="ECO:0000305"
FT   REGION          585..780
FT                   /note="Spacer"
FT                   /evidence="ECO:0000305"
FT   REGION          781..949
FT                   /note="Domain B"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         332
FT                   /note="Phosphothreonine; by CDK2"
FT                   /evidence="ECO:0000269|PubMed:11884610,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         369
FT                   /note="Phosphothreonine; by CDK4"
FT                   /evidence="ECO:0000269|PubMed:11884610,
FT                   ECO:0000269|PubMed:12006580, ECO:0007744|PubMed:23186163"
FT   MOD_RES         385
FT                   /note="Phosphothreonine; by CDK2"
FT                   /evidence="ECO:0000269|PubMed:11884610,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163"
FT   MOD_RES         640
FT                   /note="Phosphoserine; by CDK2 and CDK4"
FT                   /evidence="ECO:0000269|PubMed:11884610,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         650
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:12006580"
FT   MOD_RES         749
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         762
FT                   /note="Phosphoserine; by CDK2"
FT                   /evidence="ECO:0000269|PubMed:11884610,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163"
FT   MOD_RES         964
FT                   /note="Phosphoserine; by CDK2 and CDK4"
FT                   /evidence="ECO:0000269|PubMed:11884610"
FT   MOD_RES         975
FT                   /note="Phosphoserine; by CDK2 and CDK4"
FT                   /evidence="ECO:0000269|PubMed:11884610"
FT   MOD_RES         988
FT                   /note="Phosphoserine; by CDK2"
FT                   /evidence="ECO:0000269|PubMed:11884610,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         997
FT                   /note="Phosphothreonine; by CDK2"
FT                   /evidence="ECO:0000269|PubMed:11884610"
FT   MOD_RES         1009
FT                   /note="Phosphoserine; by CDK2"
FT                   /evidence="ECO:0000269|PubMed:11884610"
FT   MOD_RES         1041
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1013..1068
FT                   /note="SLKDINNMIRQGEQRTKKRVIAIDSDAESPAKRVCQENDDVLLKRLQDVVSE
FT                   RANH -> VR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_017496"
FT   VARIANT         1035
FT                   /note="I -> M (in dbSNP:rs8114297)"
FT                   /id="VAR_034443"
FT   MUTAGEN         640
FT                   /note="S->A: Strongly reduces phosphorylation by CDK2 and
FT                   CDK4."
FT                   /evidence="ECO:0000269|PubMed:11884610"
FT   MUTAGEN         643
FT                   /note="S->R: No effect on S-640 phosphorylation, but
FT                   strongly increases S-640 phosphorylation; when associated
FT                   with 657-A--A-660."
FT                   /evidence="ECO:0000269|PubMed:11884610"
FT   MUTAGEN         650
FT                   /note="S->A: No effect on phosphorylation by CDK2."
FT                   /evidence="ECO:0000269|PubMed:11884610"
FT   MUTAGEN         657..660
FT                   /note="KRRL->AAAA: Reduces S-640 phosphorylation by CDK2
FT                   and CDK4."
FT                   /evidence="ECO:0000269|PubMed:11884610"
FT   CONFLICT        326
FT                   /note="Missing (in Ref. 8; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        928
FT                   /note="G -> S (in Ref. 1 and 6)"
FT                   /evidence="ECO:0000305"
FT   HELIX           392..401
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           410..418
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   STRAND          419..421
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           424..442
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   STRAND          447..449
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           454..478
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           480..483
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           489..492
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           495..512
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           521..525
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           530..533
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           536..543
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           549..564
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           566..568
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           574..580
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   TURN            581..583
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           588..592
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           787..809
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           814..830
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           832..835
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           840..855
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           861..868
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           877..880
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   STRAND          881..885
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   STRAND          926..928
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           930..936
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           938..946
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   HELIX           947..949
FT                   /evidence="ECO:0007829|PDB:7SMD"
FT   STRAND          1001..1005
FT                   /evidence="ECO:0007829|PDB:5TUV"
FT   TURN            1006..1008
FT                   /evidence="ECO:0007829|PDB:5TUV"
FT   HELIX           1011..1023
FT                   /evidence="ECO:0007829|PDB:5TUV"
SQ   SEQUENCE   1068 AA;  120847 MW;  2BC4876EA04BDB31 CRC64;
     MFEDKPHAEG AAVVAAAGEA LQALCQELNL DEGSAAEALD DFTAIRGNYS LEGEVTHWLA
     CSLYVACRKS IIPTVGKGIM EGNCVSLTRI LRSAKLSLIQ FFSKMKKWMD MSNLPQEFRE
     RIERLERNFE VSTVIFKKYE PIFLDIFQNP YEEPPKLPRS RKQRRIPCSV KDLFNFCWTL
     FVYTKGNFRM IGDDLVNSYH LLLCCLDLIF ANAIMCPNRQ DLLNPSFKGL PSDFHTADFT
     ASEEPPCIIA VLCELHDGLL VEAKGIKEHY FKPYISKLFD RKILKGECLL DLSSFTDNSK
     AVNKEYEEYV LTVGDFDERI FLGADAEEEI GTPRKFTRDT PLGKLTAQAN VEYNLQQHFE
     KKRSFAPSTP LTGRRYLREK EAVITPVASA TQSVSRLQSI VAGLKNAPSD QLINIFESCV
     RNPVENIMKI LKGIGETFCQ HYTQSTDEQP GSHIDFAVNR LKLAEILYYK ILETVMVQET
     RRLHGMDMSV LLEQDIFHRS LMACCLEIVL FAYSSPRTFP WIIEVLNLQP FYFYKVIEVV
     IRSEEGLSRD MVKHLNSIEE QILESLAWSH DSALWEALQV SANKVPTCEE VIFPNNFETG
     NGGNVQGHLP LMPMSPLMHP RVKEVRTDSG SLRRDMQPLS PISVHERYSS PTAGSAKRRL
     FGEDPPKEML MDKIITEGTK LKIAPSSSIT AENVSILPGQ TLLTMATAPV TGTTGHKVTI
     PLHGVANDAG EITLIPLSMN TNQESKVKSP VSLTAHSLIG ASPKQTNLTK AQEVHSTGIN
     RPKRTGSLAL FYRKVYHLAS VRLRDLCLKL DVSNELRRKI WTCFEFTLVH CPDLMKDRHL
     DQLLLCAFYI MAKVTKEERT FQEIMKSYRN QPQANSHVYR SVLLKSIPRE VVAYNKNIND
     DFEMIDCDLE DATKTPDCSS GPVKEERGDL IKFYNTIYVG RVKSFALKYD LANQDHMMDA
     PPLSPFPHIK QQPGSPRRIS QQHSIYISPH KNGSGLTPRS ALLYKFNGSP SKSLKDINNM
     IRQGEQRTKK RVIAIDSDAE SPAKRVCQEN DDVLLKRLQD VVSERANH
//
